Text Size

Vitrous Analysis in Proliferative Diabetic Retinopathy

This study is currently recruiting participants.
Verified June 2012 by St. Erik Eye Hospital
Sponsor:
Information provided by (Responsible Party):
Anders Kvanta, St. Erik Eye Hospital
ClinicalTrials.gov Identifier:
NCT01478763
First received: November 21, 2011
Last updated: June 5, 2012
Last verified: June 2012
History of Changes
  Purpose

Analysis of vitreous proteins in patients undergoing pars plana vitrectomy for proliferative diabetic retinopathy


Condition
Proliferative Diabetic Retinopathy

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Analysis of Vitreous Proteins in Patients Undergoing Pars Plana Vitrectomy for Proliferative Diabetic Retinopathy

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by St. Erik Eye Hospital:

Biospecimen Retention:   Samples With DNA

Vitreous samples


Estimated Enrollment: 200
Study Start Date: January 2011
Estimated Study Completion Date: December 2013
Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)
Detailed Description:

To analyse and compare vitreous proteins in patients undergoing pars plana vitrectomy for proliferative diabetic retinopathy.

  Eligibility

Ages Eligible for Study:   12 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Patients undergoing pars plana vitrectomy for proliferative diabetic retinopathy

Criteria

Inclusion Criteria:

  • proliferative diabetic retinopathy with vitreous hemorrhage

Exclusion Criteria:

  • vitreous hemorrhage of other cause than proliferative diabetic retinopathy
  • previous vitrectomy
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01478763

Locations
Sweden
St. Erik Eye Hospital Recruiting
Stockholm, NonUS, Sweden, 11282
Contact: Anders Kvanta, PhD     004686723000     anders.kvanta@sankterik.se    
Sponsors and Collaborators
Anders Kvanta
Investigators
Principal Investigator: Anders Kvanta, PhD St. Erik Eye Hospital
  More Information

No publications provided

Responsible Party: Anders Kvanta, Professor, St. Erik Eye Hospital
ClinicalTrials.gov Identifier: NCT01478763     History of Changes
Other Study ID Numbers: Vitreous1
Study First Received: November 21, 2011
Last Updated: June 5, 2012
Health Authority: Sweden: Regional Ethical Review Board

Keywords provided by St. Erik Eye Hospital:
PDRP
vitreous
protein
vitrectomy

Additional relevant MeSH terms:
Diabetic Retinopathy
Retinal Diseases
Eye Diseases
Diabetic Angiopathies
Vascular Diseases
 Cardiovascular Diseases
Diabetes Complications
Diabetes Mellitus
Endocrine System Diseases

ClinicalTrials.gov processed this record on May 16, 2013